The Advent of Next-Generation Sequencing (NGS): Principles, Bioinformatics Pipelines, and Veterinary Applications

Introduction

The transition from Sanger dideoxy sequencing to massively parallel sequencing platforms, collectively termed next-generation sequencing (NGS), has fundamentally altered the landscape of molecular diagnostics and biological research. In veterinary medicine, NGS enables the simultaneous detection of multiple pathogens, the characterization of host and microbial transcriptomes, and the discovery of novel agents without a priori knowledge of sequence. This article provides a technical overview of NGS technologies, the computational methods required for data interpretation, and their specific applications in animal health diagnostics and research.

Historical Context and Technological Breakthroughs

Classical Sanger sequencing, while accurate, is limited by throughput. The advent of NGS technologies, as reviewed by Ranga et al. [1], introduced the concept of clonal amplification and parallel sequencing of millions of DNA fragments. Early platforms relied on emulsion PCR and pyrosequencing; subsequent generations adopted sequencing-by-synthesis with reversible terminators, ion semiconductor detection, and single-molecule real-time approaches. These innovations reduced per-base costs by several orders of magnitude and increased throughput from kilobases to gigabases per run [2, 3].

The core principle shared by most NGS platforms is the immobilization of a library of DNA fragments on a solid surface and the iterative interrogation of incorporated nucleotides. Beura et al. [4] highlighted how NGS data analysis has evolved from simple read mapping to complex variant calling and metagenomic classification. The paradigm shift described by Peng et al. [5] moves NGS from a tool for targeted pathogen detection to a platform for systems-level analysis of host-pathogen interactions.

Technical Foundations of NGS

Library Preparation

A typical NGS workflow begins with nucleic acid extraction, fragmentation, and adapter ligation. For DNA sequencing, genomic DNA is sheared enzymatically or mechanically to fragments of 200 to 600 base pairs. Adapters containing primer binding sites, index sequences for multiplexing, and flow cell attachment sequences are ligated. For RNA sequencing, reverse transcription and second-strand synthesis precede adapter ligation.

Sequencing Chemistry

Several sequencing chemistries are commercially available, but all rely on cyclic addition of nucleotides and signal detection. The most widely adopted method uses reversible terminator nucleotides labeled with fluorescent dyes. After each incorporation, the terminator moiety is cleaved, and the fluorophore is imaged. The process is repeated for hundreds of cycles. Ion semiconductor sequencing detects hydrogen ions released during nucleotide incorporation, using a pH-sensitive sensor array.

Read Output and Quality Metrics

NGS runs produce output in FASTQ format, which contains raw nucleotide calls and per-base quality scores (Phred scores). Read length varies from 75 base pairs (short reads) to tens of kilobases (long reads). Moradi et al. [2] emphasize that read length, depth of coverage, and per-base error rate must be considered when designing experiments, particularly for applications such as detection of minor variants or de novo assembly.

Bioinformatics Pipelines for NGS Data

The computational analysis of NGS data is a multi-step process. Beura et al. [3] outline a general pipeline: quality control (e.g., FastQC), adapter trimming, read alignment to a reference genome, variant calling, and annotation. For metagenomic applications, reads are classified by comparison against reference databases (e.g., Kraken2, Centrifuge) or by assembling contigs and performing taxonomic binning.

Table 1 summarizes the main analysis stages and common tools.

Table 1: Typical NGS Bioinformatics Pipeline Stages

Cross-linking with computational biology resources such as "Flux Balance Analysis in Metabolic Networks" and "Bayesian Networks in Systems Biology" provides further context for integrating NGS-derived data into systems biology models.

Veterinary Applications of NGS

Pathogen Detection and Metagenomics

NGS has transformed veterinary diagnostics by allowing unbiased detection of all nucleic acids present in a sample. This is particularly valuable for identifying novel or unexpected pathogens. For instance, in outbreaks of respiratory or enteric disease in poultry and swine, NGS can simultaneously detect viral, bacterial, and parasitic agents. The technique is applicable to the study of agents like "Highly Pathogenic Avian Influenza (H5N1) in Poultry" and "Porcine Reproductive and Respiratory Syndrome". Benchmarks from human diagnostics, such as the integration of NGS into routine workflows to replace low-yield testing [6], are directly translatable to veterinary oncology and infectious disease panels.

Antimicrobial Resistance Genotyping

NGS enables comprehensive profiling of antimicrobial resistance genes. For livestock-associated pathogens like "Staphylococcus aureus" and "Escherichia coli", whole-genome sequencing can identify resistance determinants and track their spread. Pipitò et al. [7] demonstrated this for HIV-1, but analogous workflows are employed for veterinary viruses and bacteria. The genomic epidemiology of "Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus" benefits from the deep coverage and single-nucleotide resolution provided by NGS.

Viral Population Genetics and Quasispecies Analysis

For RNA viruses with high mutation rates, such as "Feline Coronavirus" and "Canine Parvovirus", NGS enables the detection of minor variant populations (quasispecies). This is critical for understanding immune evasion, virulence shifts, and drug resistance. The depth of coverage achieved by NGS allows for the identification of variants present at frequencies as low as 1% to 5%.

Host Transcriptomics and Gene Expression

RNA-seq, a specific NGS application, quantifies host and pathogen transcripts. In vaccine development for "Mycoplasma bovis" or "Avibacterium paragallinarum", transcriptomic profiling can elucidate host immune responses. Beura et al. [4] noted that NGS data analysis now extends beyond simple read counts to include splice variant detection, allele-specific expression, and fusion transcript identification.

Metagenomic Surveillance in Wildlife and Batches

NGS is instrumental for surveillance programs targeting pathogens at the livestock-wildlife interface. Studies on "Tick-Borne Parasites in White-Tailed Deer" and "Avian Cholera in Waterfowl" can incorporate NGS to detect co-infections and novel genotypes. The unbiased nature of metagenomic NGS reduces the need for multiple single-target assays.

Advantages and Limitations

NGS offers several distinct advantages over conventional methods:

• High throughput: billions of bases per run.
• Multiplexing: dozens to hundreds of samples can be sequenced simultaneously.
• Discovery potential: detection of unculturable or unsuspected agents.
• Genomic resolution: identification of single nucleotide variants, indels, and structural rearrangements.

However, NGS also presents challenges. Data volumes are large, requiring substantial computational infrastructure and storage. Standardized bioinformatics pipelines are necessary to ensure reproducibility. Quality control must account for sequencing errors, index hopping, and contamination. Moradi et al. [2] discuss the technical basis and diagnostic application of NGS, underscoring the need for validation against reference methods.

The Mermaid diagram below outlines a decision tree for implementing NGS in a veterinary diagnostic setting.

flowchart TD
    A[Clinical sample or necropsy specimen] --> B{DNA/RNA extraction}
    B --> C[Library preparation]
    C --> D[Quantification and pooling]
    D --> E{Sequencing platform selection}
    E --> F[Short-read sequencer]
    E --> G[Long-read sequencer]
    F --> H[FASTQ generation]
    G --> H
    H --> I[Quality control and trimming]
    I --> J{Analysis goal?}
    J --> K[Pathogen detection]
    J --> L[Whole-genome assembly]
    J --> M[Transcriptome profiling]
    K --> N[Taxonomic classification]
    N --> O[Report pathogen identity and abundance]
    L --> P[Variant calling and annotation]
    P --> Q[Antimicrobial resistance and virulence gene profiling]
    M --> R[Expression quantification]
    R --> S[Differential expression and pathway analysis]

Integration with Existing Diagnostic Workflows

NGS can complement established methods such as PCR, ELISA, and culture. For example, in diagnosing "Infectious Coryza in Poultry", NGS can confirm mixed infections or identify serovars. In "African Swine Fever", NGS-based genomic surveillance supports outbreak tracing. The integration of NGS into routine veterinary diagnostics, as proposed by Molina et al. [6] in the human context, reduces reliance on low-yield tests and provides actionable data more efficiently.

Future Directions

The continued evolution of NGS technologies promises lower costs, longer reads, and real-time sequencing. Single-molecule platforms are already enabling direct RNA sequencing and epigenetic modification detection. Braat et al. [8] used NGS to study melanocytic tumors, highlighting the utility of targeted panels. In veterinary medicine, similar panels for canine and feline cancers are under development.

Bioinformatics will remain the bottleneck. The development of user-friendly, cloud-based pipelines and curated pathogen databases will facilitate adoption. Peng et al. [5] call for a systems-level approach, integrating NGS data with proteomics, metabolomics, and clinical metadata. This convergence, often termed "next-generation phenomics" [1], aligns with the goals of veterinary systems biology.

Conclusion

Next-generation sequencing has advanced from a research tool to an indispensable component of veterinary diagnostics and research. Its ability to generate comprehensive genomic data from complex samples enables earlier detection, better characterization, and more informed management of animal diseases. The bioinformatics frameworks described herein are essential for translating raw sequence data into actionable clinical insights.

References

[1] Ranga A, Malhotra AG, Singh J, et al. Genomic Sequencing from Sanger to Next-Generation Sequencing: Historical Context, Comparative Advances, and Prospects for Next-Generation Phenomics. OMICS. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41870192/

[2] Moradi A, Mousavi M, Maleki M, et al. Next-generation sequencing as an applicable method: from technical basis to use in medical diagnosis. Gene. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41519451/

[3] Beura A, Manjunath GK, Mahalingam S, et al. Next generation DNA sequencing data analysis and its application in clinical genomics. Pathol Res Pract. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41177096/

[4] Beura A, Dakal TC, Rajguru MS, et al. Transformative Applications and Innovations in Next-Generation Sequencing Data Analysis. J Appl Genet. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42068517/

[5] Peng Y, Wang Y, Liu L, et al. Next-generation sequencing: Driving a paradigm shift from pathogen detection to systems-level analysis. Infect Med (Beijing). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42206067/

[6] Molina LM, Pan Y, Wang Q, et al. Integrating next-generation sequencing into the routine neuroblastoma workflow identifies actionable genomic alterations and reduces low-yield karyotype testing. Virchows Arch. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41840189/

[7] Pipitò L, Cannella S, Mascarella C, et al. Next-Generation Sequencing Analysis for HIV-1 Genotyping and Drug Resistance Mutations Mapping in Sicily, Italy. Viruses. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40872843/

[8] Braat J, Trichy NS, Holic LJ, et al. The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors. Hum Pathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41831527/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.